Opioids modulate numerous central and peripheral processes including p
ain perception, neuroendocrine secretion and the immune response. The
opioid signal is transduced from receptors through G proteins to vario
us different effecters. Heterogeneity exists at all levers of the tran
sduction process. There are numerous endogenous ligands with differing
selectivities for at least three distinct opioid receptors (mu, delta
, kappa) G proteins activated by opioid receptors are generally of the
pertussis toxin-sensitive Gi/Go class, but there are also opioid acti
ons that are thought to involve Gq and cholera toxin-sensitive G prote
ins. To further complicate the issue, the actions of opioid receptors
may be mediated by G-protein alpha subunits and/or beta gamma subunits
. Subsequent to G protein activation several effecters are known to or
chestrate the opioid signal. For example activation of opioid receptor
s increases phosphatidyl inositol turnover, activates K+ channels and
reduces adenylyl cyclase and Ca2+ channel activities. Each of these ef
fecters shows considerable heterogeneity. In this review we examine th
e opioid signal transduction mechanism. Several important questions ar
ise: Why do opioid ligands with similar binding affinities have differ
ent potencies in functional assays? To which Ca2+ channel subtypes do
opioid receptors couple? Do opioid receptors couple to Ca2+ channels t
hrough direct G protein interactions? Does the opioid-induced inhibiti
on of vesicular release occur through modulation of multiple effecters
? We are attempting to answer these questions by expressing cloned opi
oid receptors in GH(3) cells. Using this well characterized system we
can study the entire opioid signal transduction process from ligand-re
ceptor interaction to G protein-effector coupling and subsequent inhib
ition of vesicular release.